MedTrace Logo

Effect of Peer Support Intervention on Medication Adherence, Self-care and Knowledge Among Patients With Diabetes

NCT07145983 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-03-12

Study results available
· View outcomes & findings →

Summary

The goal of this interventional study is to learn about the effect of a peer support group intervention on adherence, self-care practice, and knowledge among diabetic patients on follow-up care. The main question it aims to answer is:

* Does participation in a peer support group improve medication adherence, self-care behaviors, and diabetes knowledge compared to standard care?
* Participants with diabetes who are already receiving follow-up care at Ayder Comprehensive Specialized Hospital(ACSH) will be randomly assigned to either a peer support group (intervention group) or continue their usual follow-up care (control group). Outcomes will be measured through validated questionnaires and pill counts over the study period.

Conditions

  • Peer Influence
  • Medication Adherence
  • Self Care

Interventions

BEHAVIORAL

Structured Diabetes Education on medication Adherence and self care

Lived-experience facilitation, goal setting, real-world problem solving, and ongoing peer accountability not provided in standard clinician-led education. Peer-led, group-based sessions emphasizing lived experiences, problem-solving, and mutual support. Participants meet regularly in small groups facilitated by trained peers with diabetes. Includes structured booster follow-ups and SMS reminders to reinforce adherence and self-care.

Sponsors & Collaborators

  • Mekelle University

    collaborator OTHER

  • Addis Ababa University

    lead OTHER

Principal Investigators

  • Halefom K Haile, Msc · Addis Ababa University, Adigrat university

  • Teferi G Fenta, Professor · Addis Ababa University

  • Bruck M Habte, PhD · Addis Ababa University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2025-07-30
Completion
2025-08-01

Countries

  • Ethiopia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07145983 on ClinicalTrials.gov